Internal Medicine, Hematology & Oncology · Boston, MA
NPI
1881897023
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
133 Brookline Ave
Boston, MA, 02215
Phone (617) 421-5950
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
4,889 services
Medicare patients, 2024
24
Average age 68
Drug cost, 2024
$4.2M
1,291 prescriptions
Company payments, 2025
$22.51
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hao Wang was code J7030 (infusion, normal saline solution , 1000 cc), 32 times for 13 patients. In total Hao Wang billed 4,889 services in 35 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7030 Infusion, normal saline solution , 1000 cc | Office | 32 | 13 | $1.94 | $62.18 |
By year: 2022 $27K for 1,578 services; 2024 $50K for 4,889 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hao Wang prescribed most often to Medicare patients was Abiraterone Acetate, with 106 prescriptions and refills. In total Hao Wang wrote 1,291 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 106 | 142 | 14 | $21K |
| Letrozole Generic | 103 | 305 | 34 | $2,082 |
| Acyclovir Generic | 98 | 142 | 20 | $1,698 |
| Prednisone Generic | 89 | 150 | 19 | $685 |
| Dexamethasone Generic | 72 | 77 | 23 | $1,013 |
| Potassium Chloride Generic | 70 | 189 | 28 | $2,592 |
| Hydroxyurea Generic | 57 | 156 | 14 | $2,318 |
| Lenalidomide Generic | 50 | 50 | Under 11 | $596K |
| Xarelto Rivaroxaban | 41 | 51 | Under 11 | $24K |
| Xtandi Enzalutamide | 34 | 34 | Under 11 | $378K |
| Eliquis Apixaban | 34 | 34 | Under 11 | $22K |
| Tamoxifen Citrate Generic | 33 | 98 | Under 11 | $802 |
| Ibrance Palbociclib | 31 | 31 | Under 11 | $480K |
| Levothyroxine Sodium Generic | 31 | 64 | Under 11 | $769 |
| Anastrozole Generic | 30 | 91 | Under 11 | $851 |
Brand drugs: 328 claims; generic drugs: 963 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hao Wang $22.51 ($22.51 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $22.51.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $22.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.